BDP1P

Across TCGA pan-cancer cohorts, BDP1P RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated BDP1P data layer.

The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where higher BDP1P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated BDP1P expression acts as an unfavorable survival marker, although some lineages such as BRCA and LUSC show a favorable association.

PAAD, BRCA, and THCA are the cancer types where BDP1P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PAAD	OS	Tertile	All	0.399	0.651	<.001	72	view →
BRCA	OS	Tertile	IV	0.908	0.442	.021	30	view →
THCA	OS	Tertile	II,III,IV	0.314	0.949	.005	25	view →
KIRC	DFS	Quartile	III,IV	0.476	0.663	.008	19	view →
CHOL	OS	Tertile	III,IV	0.275	0.886	.045	18	view →
TGCT	OS	Tertile	III,IV	0.501	1.000	.014	18	view →
LUSC	DFS	Tertile	All	0.988	0.739	.007	18	view →
PRAD	DFS	Tertile	All	0.895	0.731	.007	18	view →
KICH	DFS	Tertile	All	0.642	0.899	.013	12	view →
SKCM	DFS	Quartile	All	0.701	0.591	.010	12	view →
ACC	OS	Median	IV	0.832	0.350	.031	8	view →
ESCA	DFS	Tertile	III,IV	0.510	0.291	.023	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

BDP1P–PAAD (OS)

Open the PAAD breakdown →